Health In Tech (HIT) Stock Price, News & Analysis

Company Overview

Health In Tech, Inc. is a United States-based insurance technology company that provides a digital platform for the self-funded health benefits market. Its technology is designed to connect employers, insurance brokers, third-party administrators, and insurance carriers through a streamlined process for evaluating, selecting, and administering health benefit plans.

The company’s platform supports activities such as plan quoting, proposal management, enrollment, benefits administration, and ongoing communication among participants in the insurance process. Health In Tech focuses primarily on self-funded and level-funded health plans, which allow employers to assume greater responsibility for healthcare costs while using third-party providers and stop-loss insurance to manage administration and risk.

Health In Tech serves participants in the U.S. employee benefits and commercial health insurance markets. Its technology-based approach is intended to reduce administrative complexity, improve transparency, and make the distribution of health benefit products more efficient for employers and their benefits advisers.

Key Stats

• Today's Range: $0.62 to $0.65
• 50-Day Range: $0.63 to $1.12
• 52-Week Range: $0.61 to $3.35
• Volume: 10,258 shs
• Average Volume: 233,396 shs
• Market Capitalization: $41.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $3.50
• Consensus Rating: Moderate Buy

Health In Tech Stock Analysis - MarketRank™

Health In Tech scored higher than 62% of companies evaluated by MarketBeat, and ranked 351st out of 870 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Health In Tech has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 1 strong buy rating, 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

Health In Tech has a consensus price target of $3.50, representing about 448.6% upside from its current price of $0.64.

Amount of Analyst Coverage

Health In Tech has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Health In Tech is -9.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Health In Tech is -9.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.62% of the float of Health In Tech has been sold short.

Short Interest Ratio / Days to Cover

Health In Tech has a short interest ratio ("days to cover") of 0.68, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Health In Tech has recently decreased by 33.47%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Health In Tech does not currently pay a dividend.

Dividend Growth

Health In Tech does not have a long track record of dividend growth.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 0.89

News Sentiment

Health In Tech has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Health In Tech this week, compared to 2 articles on an average week.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Health In Tech insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $16,249.00 in company stock.

Percentage Held by Insiders

77.65% of the stock of Health In Tech is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Health In Tech has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/13/2026
• Today: 10/16/2026
• AGM 2026: 11/10/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NASDAQ:HIT
• Previous Symbol: NASDAQ:HIT
• CIK: 2019505
• Web: healthintech.com
• Phone: (888) 373-0333
• Fax: N/A
• Employees: 91
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Health In Tech: $3.50
• High Price Target: $4.00
• Low Price Target: $3.00
• Potential Upside/Downside: +448.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $32.83 million
• Price / Sales: 1.27
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 65,535,000
• Free Float: N/A
• Market Cap: $41.81 million
• Optionable: N/A
• Beta: 2.81